. To investigate spen function in the context of RTK signaling, we examined the consequences of spen loss-of-function mutations on embryonic CNS development. We found that spen was required for normal migration and survival of MGCs and that embryos lacking spen had CNS defects strikingly reminiscent of those seen in mutants of several known components of the DER signaling pathway. In addition, spen interacted synergistically with the RTK effector pointed. Using MGC-targeted expression, we found that increased Ras signaling rescued the lethality associated with expression of a dominant-negative spen transgene. Therefore, spen encodes a positively acting component of the DER/Ras signaling pathway.
Results and discussion
To examine the consequences of complete loss of spen function, we generated spen germline clones using the ovo D -FLP/FRT system [8] . Embryos lacking both maternal and zygotic spen will be referred to as 'spen mutants'. These mutants exhibited moderate defects in CNS morphology, as visualized by anti-Elav antibody, a pan-neuronal marker. In stage 16 spen mutant embryos, the space separating the two longitudinal halves of the CNS was reduced compared with the wild type and, in some segments, the two sides were completely collapsed across the midline (Figure 1a,b) . Because of this collapse, the midline neurons were difficult to detect; however, labeling with the antibody 22C10 revealed that the ventral midline neurons were present and had no obvious defects in their projections (data not shown). Because such collapsed CNS phenotypes might be indicative of defects in the midline, spen mutant embryos were examined for expression of the MGC-specific marker Slit [9] . Initial determination of the MGCs appeared normal in spen mutants (Table 1 and Figure 1h ,i). The first detectable defects occurred at late stage 12/early stage 13 when the MGCs normally initiate their migration. In the wild type, the glial cells migrate in a tightly packed configuration along the dorsal surface of the ventral nerve cord, whereas in spen mutants, the glia migrated aberrantly and became spread out in a more diffuse pattern (Figure 1j,k) . The results of our analyses differ from a recent report that excessive numbers of MGCs are initially specified in spen mutants [7] (see Supplementary material for additional discussion). Using the Slit-lacZ nuclear enhancer trap marker to count the MGCs, we detected comparable numbers of MGCs in the wild type and in spen mutants up until stage 13, and a reduction in MGC number in spen mutants beginning at stage 14 (Table 1) . Thus, in our spen mutants, which appear to be genetic and protein nulls, normal numbers of MGCs are initially specified, a phenotype consistent with what has been reported for other DER pathway mutants [4] .
By stage 16, in a wild-type embryo, the Slit-positive MGCs have migrated and elongated to ensheathe the anterior commissure (AC) and posterior commissure (PC) axons, thereby maintaining proper separation and bundling ( Figure 1d ). In similarly staged spen mutant embryos, the MGCs had not properly migrated or wrapped themselves around the commissure bundles ( Figure 1e ). In addition, while apoptosis reduces the number of MGCs in wild type embryos from ~8 per segment at stage 13 down to only ~3 per segment by stage 16-17, in spen mutants this reduction was even more drastic, leaving only 1-2 MGCs per segment (Table 1 and Figure 1f ,g,l,m). Thus, in spen mutants, although initiation of MGC differentiation appears normal, the later aspects of glial development, including migration, wrapping, and survival or maintenance of the MGC fate, are defective. To confirm that Spen was expressed in the MGCs at stage 13 when its function is required, embryos carrying the MGC-specific enhancer trap line AA142, were double labeled with anti-β-galactosidase and anti-Spen antibodies ( Figure 1c ). The highest level of Spen expression was seen in the MGCs.
Because defects in glial cell development are likely to perturb organization of the CNS, spen mutant embryos were labeled with the antibody BP102, which highlights all axon tracts in the CNS. As predicted, the AC and PC axon bundles were not properly organized or separated and, in some segments, were completely fused ( Figure 2a ,b). In addition, the two longitudinal connectives appeared closer together than normal and were occasionally fully collapsed across the midline (Figure 2a ,b). Staining with the anti-Fasciclin II (FasII) antibody, which highlights a distinct set of three axon bundles in each longitudinal branch, further clarified this phenotype. These longitudinal axon tracts never cross the midline in a wildtype embryo ( Figure 2c ). In contrast, the FasII-positive axons crossed and recrossed the midline in spen mutants, producing a fragmented and disorganized longitudinal axonal array ( Figure 2d ).
In Drosophila, the genes rhomboid, Star, pointed and spitz, all positively acting components of the DER pathway, share a characteristic CNS phenotype similar to that of spen mutants [1] . Specifically, whereas the proper number of MGCs are initially specified, they later migrate abnormally and eventually degenerate and die [3, 4] . The phenotypic similarities between spen and the DER pathway genes, as well as our isolation of spen as an enhancer of an activated yan allele, are consistent with the hypothesis that spen may be a positively acting factor in the DER/Ras signaling pathway. To explore this possibility, we first determined whether spen and the RTK pathway effector 944 Current Biology Vol 10 No 15
Figure 2
The spen mutants exhibit severe axon guidance defects. Dissected CNS from stage 16 embryos oriented with anterior to the top. Table 1 The spen gene is required for midline glial cell survival.
Wild type spen AH393
Stage 13 The number of segments counted (n) is given in parentheses.
pointed (pnt) interact synergistically in the midline. The expectation is that a reduction in activity of a proven positive effector of the DER pathway, such as pnt, should dominantly enhance the spen phenotype. Embryos lacking maternal spen can be partially rescued by zygotic spen expression from a paternally inherited wild-type allele (we refer to this genotype as spen/+). Stage 15-17 spen/+ embryos appeared phenotypically wild type, with onlỹ 4% of the embryos exhibiting CNS defects ( Table 2) . Embryos heterozygous for a pnt loss-of-function mutation (pnt/+) have no apparent dominant defects ( Table 2) . Reducing the pnt dosage in the spen/+ background increased the frequency of axonal defects to ~25% ( Table 2 ). The predominant phenotype was reduced separation between the two longitudinal axon pathways and a single inappropriate crossing of the midline by one of the FasII-positive axon tracts (Figure 2e ). This dose-sensitive interaction between pnt and spen strongly supports a role for spen as either a positively acting component of the DER pathway or as a component of a parallel pathway synergizing with DER during MGC development.
To investigate further the connection between spen and DER/Ras signaling in the MGCs, we generated a putative dominant-negative spen transgene that truncates the carboxy-terminal ~1500 amino acids, including the highly conserved SPOC domain. When transfected into S2 cultured cells, this construct (Spen∆C) was expressed at high levels and localized to the nucleus just as we had found for the endogenous wild-type Spen protein (data not shown). Ubiquitous expression of Spen∆C was unable to rescue the lethality or phenotypes associated with spen mutants, implying an essential function for the conserved carboxyterminal SPOC domain. To determine whether Spen∆C might behave as a dominant-negative mutation, the Slit-Gal4 driver was used to induce high levels of expression specifically in the MGCs. MGC-specific expression of Spen∆C resulted in completely penetrant lethality (Figure 3 ; see Supplementary material for additional discussion). In contrast, and consistent with the lack of primary neuronal defects associated with spen mutants, pan-neural expression of Spen∆C using the Elav-Gal4 driver did not compromise the viability or patterning of the fly. To test the hypothesis that the Slit-Gal4/Spen∆C lethality might be due to compromised RTK/Ras pathway signaling, we determined whether increasing the level of DER/Ras pathway signaling, specifically in the MGCs, could compensate for the reduction in spen function associated with expression of the dominant-negative Spen∆C transgene. Whereas Slit-Gal4-driven expression of either an activated Ras V12 or the Spen∆C transgene resulted in lethality, flies expressing both Ras V12 and Spen∆C in the MGCs were viable and appeared normally patterned. The mutual suppression was extremely penetrant as over 50% of the expected class of flies was recovered (Figure 3) . Similar, but less penetrant, rescue was obtained when Spen∆C and a secreted form of the DER ligand Spitz were coexpressed in the MGCs. Together, these results strongly suggest that spen functions autonomously in the MGCs, acting either downstream of or in parallel to Ras as a positive effector or regulator of RTK signaling.
Although the molecular mechanisms underlying Spen function in the RTK/Ras pathway remain to be elucidated, given its membership of the RRM family [5] [6] [7] , one possibility is that Spen might directly regulate the processing and/or stability of specific transcripts to generate functionally distinct protein isoforms in response to, or required for, Ras signaling events. Post-transcriptional regulation of gene expression allows quick responses to external or developmental signals, and RRM family members have been shown to mediate many different cellular processes including mRNA splicing, stabilization, localization and Brief Communication 945 Table 2 The spen gene interacts synergistically with pointed. The axon guidance defects were detected by staining with anti-Fas II antibody. Only stage 15-17 embryos were examined and counted. n, number of embryos counted. M, maternal; P, paternal.
Percentage of embryos

Figure 3
Increased DER signaling in the midline glia suppresses the lethality associated with overexpression of the putative dominant-negative Spen∆C construct. Spen∆C, Ras V12 and secreted-Spitz (Sspi) were expressed as UAS transgenes under control of the MGC-specific Slit-Gal4 driver. The survival rate was calculated from the ratio of the actual number of adult flies recovered and the expected number of flies of each particular genotype. At least 100 flies were counted in each experiment. transport [10] . Two attractive potential targets of such activity in the CNS are the Ras pathway effector pointed and the zinc finger transcription factor tramtrack. Both genes produce alternatively spliced transcripts and are required in the MGCs [11] [12] [13] . The synergistic interactions we have detected between spen and pointed make pointed a particularly appealing candidate. A third possibility, given that we isolated spen as an enhancer of an activated yan allele, is that Spen might function to destabilize yan transcripts in response to RTK-initiated signals. In this model, spen would contribute a second level of post-translational regulation that would reinforce the transient mitogen-activated protein (MAP) kinase signal that downregulates Yan protein, thereby stabilizing release from the Yan-mediated block to differentiation. In all these scenarios, spen could either function in parallel to the Ras/MAP kinase cascade, or could itself be directly regulated or activated by the pathway. 
Supplementary material
Supplementary results and discussion
MGC-specific overexpression of Spen∆C resulted in completely penetrant lethality. The prediction is that, if Spen∆C acts as a dominant-negative mutant, then overexpression of the transgene should result in defects in the MGCs similar to those seen in spen mutants. To address this question, the phenotypes associated with Spen∆C overexpression were examined. Overexpression of Spen∆C specifically in the MGCs caused ~50% embryonic lethality. The remaining animals died at later stages, with at least some dying late during pupariation. None were able to eclose. Anti-FasII antibody staining of these embryos did not reveal any obvious defects in the CNS (data not shown). We reasoned that the lack of CNS defects associated with Spen∆C expression might be due to high levels of endogenous Spen. To test this hypothesis, Spen∆C was overexpressed in the spen zygotic null mutant background; spen zygotic null mutants were embryonic lethal but lacked major CNS defects because of the heavy maternal contribution ( Figure S1a ).
Overexpression of Spen∆C in the spen zygotic null background caused severe CNS defects very similar to those seen in spen maternal and zygotic nulls ( Figure S1b ).
Thus, Spen∆C appears to function as a dominant-negative mutant in vivo.
To confirm that Spen was expressed in the MGCs at the time when the initial defects were detected, spen mutants were double labeled with anti-Spen antibody and an MGC-specific enhancer trap line AA142. The strongest Spen expression was observed in the MGCs ( Figure S2 ).
Using the Slit-lacZ enhancer trap line to count the number of MGCs in spen versus wild-type embryos, we found no significant difference in number in stage 12/13 embryos. At these stages, the primary defect associated with spen mutants appeared to be aberrant MGC migration. This defect manifested itself as a failure of the MGCs to migrate anteroposteriorly in a tightly packed configuration along the dorsal surface of the ventral nerve cord. Instead, the MGCs in spen mutants migrated more laterally and became spread out in a scattered and disorganized pattern along the ventral nerve cord ( Figure S3 ). The migration defect gave the initial appearance that there may be more MGCs in spen mutants than in the wild type; careful counting of the Slit-lacZ-positive nuclei suggested that this was not the case, however. Nevertheless, by stage 17, the number of MGCs was significantly reduced in spen mutants relative to the wild type. To make sure that our analyses were not somehow biased by using only Slit-lacZ to mark the MGCs, we examined expression of another MGC marker, Single-minded (Sim)
[S1]. Double labeling experiments revealed an almost precise overlap of the Sim and Slit markers in both the wild type (data not shown) and in spen mutants ( Figure  S3 ). Specifically, at stage 13, there was no indication of Sim-positive MGCs that did not also express Slit-lacZ. By stage 17, both markers revealed a reduction in MGC number in spen mutants relative to wild type (data not shown). Thus, it appears that, in spen mutants, normal numbers of MGCs are initially specified, but later migrate aberrantly, thereby compromising their ability either to survive or to maintain the MGC fate.
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